Medical Blue CBD by Panoramix Genetics
Blue family indica × CBD-rich donor
Medical Blue CBD is an indica-dominant cultivar developed in Europe by Panoramix Genetics, prioritizing balanced effects and symptom management over high potency. It combines the berry notes of classic indica indicas with a CBD-rich profile, making it suitable for users seeking clarity and calm.
Appearance
This strain presents a compact, indica-typical structure, ideal for indoor cultivation. Plants typically reach 80-120 cm indoors, featuring tight internodes and broad leaflets. Flowers are dense and conical, often displaying purple and blue hues under cooler temperatures due to anthocyanin expression. Resin production is robust, resulting in trichome-covered buds.
The finished buds are dense and compact, often described as berry-sized. They possess a frosty, silver-green appearance, sometimes accented with subtle violet tones. Pistils are typically cream to tangerine. Properly cured, the buds are slightly tacky and resilient.
Aroma & Flavor
The aroma is characterized by classic Blue-family notes of ripe blueberries and wild berries, complemented by a faint violet scent. A cool, creamy sweetness, reminiscent of vanilla or whipped cream, underlies the fruity notes. A grounding base of earth and wood adds complexity without being overpowering.
Upon grinding, the aroma intensifies, releasing jammy fruit notes with a peppery finish. In vapor form, berry and floral tones are prominent at lower temperatures, while higher temperatures reveal a woody-spice backbone. The flavor profile is layered, combining sweet, floral, and spicy elements.
Effects
Medical Blue CBD is recognized for delivering balanced and approachable effects. Users often report a sense of calm and focus, without overwhelming psychoactivity. This makes it a suitable option for daytime use for many individuals seeking symptom relief while maintaining clarity.
Terpenes & Cannabinoids
While specific percentages are not provided, the terpene profile is expected to include Myrcene, Caryophyllene, and Linalool, with potential contributions from Pinene and Humulene. The cannabinoid profile is typically balanced, often falling into a 1:1 to 0.5:1 THC to CBD ratio, emphasizing CBD content for therapeutic applications.
Growing
Medical Blue CBD is considered manageable for indoor cultivation, particularly in smaller spaces or micro-grows. It exhibits indica-like growth traits, including a compact stature and a relatively fast flowering period, typically around 8 to 9 weeks. The plant is noted for being forgiving in terms of nutrition and canopy control.
Origins & Lineage
Developed by Panoramix Genetics, Medical Blue CBD emerged from European craft breeding as a medicinal cultivar. It is understood to be a cross between a classic Blue-family indica, contributing berry aromas and indica morphology, and a CBD-dominant donor strain. The breeding focused on creating a functional, aromatic plant with a predictable cannabinoid ratio for therapeutic use.